Sinogen Biopharma
Boston
About Sinogen Biopharma
Sinogen Biopharma is founded with a vision to bridge China's biotech innovation to the US pharma market. The company licenses and develops innovative drugs from China.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $13.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2023)
- Website: huajinpharmtech.com
- Phone: 020 89853002
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/sinogen-biopharma-14032 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.